Questions about OTC or prescription medications while pregnant or nursing?
Call our experts.
Monday – Friday, 8am – 5pm CT
1 (806) 352-2519
The American Academy of Pediatrics recommends exclusive breastfeeding for the first six months of life and supports the continuation of breastfeeding through the first year of life along with the initiation of other foods. Most mothers make the decision on whether or not they will breastfeed either prior to or during pregnancy.
Smoking is a common social practice worldwide. It is estimated that around 18% of US adults smoke.1The CDC estimates that more than 16 million Americans have diseases due to smoking.2Because awareness of smoking hazards has been increased, there is a new player in the market, E-cigarettes, which are being marketed as a healthier and safer alternative to cigarettes.
Pregnancy leads to a range of skin changes among women. Some women experience no skin changes while others can experience severe acne, discoloration, or pigmentation. Acne is a common concern among pregnant women. Various treatments are available, but the safety of these modalities during pregnancy should be a concern. Current evidence for the safety of acne treatment is limited. A generalized...
Insect bites are certainly annoying, but they can also transmit disease. In the USA alone, insect bites can transmit Lyme disease, Rocky Mountain spotted fever, chikungunya, and dengue fever to name a few.
Folic acid is the synthetic form of folate, a water-soluble B vitamin that takes part in several critical functions in the human body. The active form of folate is tetrahydrofolic acid. It serves in one carbon reductions reactions.
Recently, the InfantRisk Center was asked to comment on the use of a new, extended-release bupivicaine product called Exparel. This drug is applied to surgical wounds and provides local anasthesia over then next 3-4 days. Some doctors are beginning to use it with C-sections and have some concerns about its safety profile in breastfeeding mothers. This is what we said:
About the InfantRisk Center Team
Thomas Hale, Ph.D., R.Ph., is a professor of pediatrics and associate dean of research at Texas Tech University Health Sciences Center and acting executive director of the InfantRisk Center.
Hale is considered one of the foremost expert in the field of perinatal pharmacology and the use of medications by pregnant and breastfeeding mothers.
The vision of the InfantRisk Center is to create a new body of drug information concerning the safety of medications and their use during pregnancy and lactation. Additionally, the center will expand, enhance and disseminate knowledge regarding the use of medications and other environmental chemicals by pregnant and breastfeeding women worldwide.
Dr. Baker graduated from the University of Texas Southwestern and completed her residency training at Parkland Health and Hospital System in Dallas, TX. She is Board Certified by the American Board of Obstetrics and Gynecology and is a Fellow of the American College of Obstetricians and Gynecologists.
Dr. Baker has a combined private and academic OB/GYN practice with the University Physicians at Texas Tech Health Sciences Center in Amarillo. She is interested in teen pregnancy, postpartum depression, and promoting preventive medicine for the women of the Texas Panhandle, as well as Resident and Student education and serves as the Residency Director.